Logotype for E I D Parry India Limited

E I D Parry India (EIDPARRY) Q4 25/26 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for E I D Parry India Limited

Q4 25/26 earnings summary

29 May, 2026

Executive summary

  • Global sugar markets softened in FY 2026, shifting to surplus with prices declining sharply year-over-year.

  • FY 2025-26 was challenging, with a focus on disciplined execution, operational efficiency, and portfolio reshaping for long-term value creation.

  • Strategic exits and resets included the closure and liquidation of the loss-making refinery (PSRIPL), with all related financial obligations settled.

  • Domestic sugar production in India recovered, led by Maharashtra and Karnataka, with stable output in Uttar Pradesh.

  • Priorities for FY27 include strengthening core businesses, margin improvement, working capital management, and digital transformation.

Financial highlights

  • Consolidated revenue for FY26 was Rs. 38,534 crore, up 22% year-over-year, but operational EBITDA was impacted by exceptional items and subsidiary restructuring.

  • Standalone revenue for FY26 was Rs. 3,120 crore, slightly down from Rs. 3,168 crore in FY25, with a standalone loss after tax of Rs. 708 crore, mainly from provisions and impairments.

  • Sugar segment Q4 revenue rose 14% year-over-year to INR 466 crore, driven by higher exports and release quota.

  • Distillery Q4 revenue reached INR 275 crore, up from INR 268 crore year-over-year, but profit declined due to higher input costs and lower realizations.

  • Consumer Product Group (CPG) Q4 revenue declined 48% to INR 115 crore due to strategic model recalibration.

Outlook and guidance

  • CPG segment aims to break even within 6–8 quarters and targets single-digit EBITDA margin by decade-end.

  • FY27 will focus on maximizing revenue streams across sugar, co-generation, and distillery segments, with continued emphasis on cost reduction and operational efficiency.

  • New jaggery facility in Karnataka expected to be commissioned by end of FY27 Q3.

  • Nutraceuticals to focus on capacity utilization, new product launches, and efficient operations.

  • Positive outlook for ethanol blending increases, with government intent to move towards E30, supporting higher capacity utilization.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more